Delta agonist hydroxy bioisosteres: the discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability.

[1]  T. Graczyk,et al.  Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859). , 2008, Journal of medicinal chemistry.

[2]  T. Steckler,et al.  4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as non-peptidic selective delta-opioid agonists with potential anxiolytic/antidepressant properties. Part 2. , 2007, Bioorganic & medicinal chemistry letters.

[3]  M. Trevethick,et al.  Highly potent and selective zwitterionic agonists of the δ-opioid receptor. Part 1 , 2006 .

[4]  J. Bidlack,et al.  8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines. , 2001, Bioorganic & medicinal chemistry letters.

[5]  R. M. Jones,et al.  Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphone. , 2000, Organic letters.

[6]  S. Buchwald,et al.  Palladium-catalyzed intermolecular coupling of aryl halides and amides. , 2000, Organic letters.

[7]  J. Bidlack,et al.  8-Aminocyclazocine analogues: synthesis and structure-activity relationships. , 2000, Bioorganic & medicinal chemistry letters.

[8]  J. Reek,et al.  An efficient, palladium-catalysed, amination of aryl bromides , 1999 .

[9]  S. Buchwald,et al.  Palladium-catalyzed amination of aryl halides and sulfonates , 1999 .

[10]  S. Buchwald,et al.  Preparation of 2-amino-2′-hydroxy-1,1′-binaphthyl and N-arylated 2-amino-1,1′-binaphthyl derivatives via palladium-catalyzed amination , 1999 .

[11]  P B Bradley,et al.  International Union of Pharmacology. XII. Classification of opioid receptors. , 1996, Pharmacological reviews.

[12]  John P. Wolfe,et al.  An Improved Catalyst System for Aromatic Carbon−Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates , 1996 .

[13]  M. Max,et al.  The analgesic efficacy of intrathecal d-ala2-d-leu5-enkephalin in cancer patients with chronic pain , 1985, Pain.

[14]  V. Hruby,et al.  Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. , 1984, The Journal of pharmacology and experimental therapeutics.

[15]  R. Rapaka,et al.  Development of Delta Opioid Peptides as Nonaddicting Analgesics , 2004, Pharmaceutical Research.

[16]  J. Bäckvall,et al.  Sulfonylmercuration of conjugated dienes. A facile route to allyl- and dienyl-sulfones , 1985 .